Julia Sepulveda Diaz, PhD
Publication Date
Keywords
CEO
International Partnership Leader
Decision making
Collaborative research & innovation manager
user needs
Company roadmap
Risk assessment
MIC strategy
Your microfluidic SME partner for Horizon Europe
We take care of microfluidic engineering, work on valorization and optimize the proposal with you
Julia Sepulveda is CEO at the Microfluidics Innovation Center (MIC)
Today, she manages the Microfluidics Innovation Center, monitors the progress of multiple collaborative projects, and handles risk detection/prevention.
She also coordinates the R&I topics to align them with the MIC’s strategy, philosophy, and vision, as well as end users’ needs.
Julia Sepulveda’s experience:
- 2024: CEO at the Microfluidics Innovation Center (MIC).
Determine the roadmap of the company, coordinating the team at the MIC, project monitoring, risk assessment, decision making. Ensuring a positive and open work environment.
- 2019: International Partnership Leader, Elvesys
- Coordination of innovative project proposals implicates a microfluidic solution for current research problems using our proprietary instruments and internal know-how on flow management, aiming to lower the barriers to implementing microfluidics by non-experienced researchers.
- Management of PhD students and post-doctoral fellows in the context of collaborative projects funded by the European Commission, i.e., Marie Sklodowska Curie Actions (Innovative Training Networks and Individual Fellowships).
- Contact and establishment of new international collaborations with researchers from academia and industry.
- 2018: Collaborative research & innovation manager, Elvesys
- Contact and establish new international collaborations with researchers from academia and industry to bring innovative microfluidic solutions to current problems in diverse fields, including medical, environmental, and chemical. These solutions include organ-on-chip and lab-on-chip systems.
- Management of multiple European projects at the company level (as partners). Tasks include discussions with the consortia, meeting deliverables and milestones on time, and technical advisors, mostly at the interface of microfluidics and biology or biochemistry.
- 2-years post-doctoral fellowship on new cell-based models of neuroinflammation for drug screening, particularly for Parkinson’s disease (Brain and Spine Institute, Paris)
- Technology transfer engineer (Université Paris-Est Créteil)
- PhD in cell biology, glycobiology (biology of complex sugars in the extracellular matrix), and neurodegenerative diseases related to protein malfunction (proteinopathies, e.g. Alzheimer’s disease) (Université Paris-Est Créteil)
- Master in Biochemistry (Mexico)
- Chemical Engineering degree (Mexico)